(January 4, 2017, 1:08 PM EST) -- CHARLESTON, S.C. — The South Carolina federal judge overseeing the Lipitor diabetes multidistrict litigation on Jan. 3 granted partial summary judgment to defendant Pfizer Inc., ordered all plaintiffs to show cause why he should not grant summary judgment in their cases and suggested that no more cases be transferred into the MDL (In Re: Lipitor [Atorvastatin Calcium] Marketing, Sales Practices and Products Liability Litigation, MDL Docket No. 2502, No. 14-mn-2502, D. S.C., Charleston Div.)....